Page last updated: 2024-10-25

deferoxamine and Skin Ulcer

deferoxamine has been researched along with Skin Ulcer in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Skin Ulcer: An ULCER of the skin and underlying tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tchanque-Fossuo, CN1
Dahle, SE1
Buchman, SR1
Isseroff, RR1
Farzan, R1
Moeinian, M1
Abdollahi, A1
Jahangard-Rafsanjani, Z1
Alipour, A1
Ebrahimi, M1
Khorasani, G1

Reviews

1 review available for deferoxamine and Skin Ulcer

ArticleYear
Deferoxamine: potential novel topical therapeutic for chronic wounds.
    The British journal of dermatology, 2017, Volume: 176, Issue:4

    Topics: Administration, Cutaneous; Chronic Disease; Deferoxamine; Humans; Iron; Siderophores; Skin Ulcer; Wo

2017

Other Studies

1 other study available for deferoxamine and Skin Ulcer

ArticleYear
Effects of amniotic membrane extract and deferoxamine on angiogenesis in wound healing: an in vivo model.
    Journal of wound care, 2018, Jun-01, Volume: 27, Issue:Sup6

    Topics: Amnion; Angiogenesis Inducing Agents; Animals; Deferoxamine; Disease Models, Animal; Drug Synergism;

2018